InvestorsHub Logo
Followers 116
Posts 1882
Boards Moderated 0
Alias Born 11/22/2017

Re: flipper44 post# 244812

Thursday, 09/19/2019 4:22:55 PM

Thursday, September 19, 2019 4:22:55 PM

Post# of 709726

Cognate BioServices: https://www.cognatebioservices.com/

Welcome to Cognate BioServices, Your CDMO Commercialization Partner.

A commitment to commercial readiness and PAI inspection for personalized and off-the-shelf cellular immunotherapy products including but not limited to, CAR-T, TCR, TIL, MIL, DC, and NK cells.



Clinical and Commerical Manufacturing

Cognate has unparalleled capabilities for autologous and allogeneic cell and cell-mediated gene therapy products such as
CAR-T, TCR, TIL, MIL, DC, NK cell derived cell and cell-mediated gene-based immunotherapies as well as a broad spectrum of regenerative medicine products. Our international manufacturing expertise combined with a broad spectrum of targeted services for effective and optimized commercialization means the highest quality products will get to the patients who need them most -- when they need them.



On August 26, 2019 / Press Releases

Cognate BioServices Secures Growth Capital Investment from EW Healthcare to Continue to Expand Commercial Manufacturing Capacity and Services for the Cellular Therapies Industry


The capital raise and partnership with EW will further support Cognate’s commercial manufacturing infrastructure and scale up activities for its clients and prospects. This partnership with EW further secures the Company’s future as a leading CDMO in the commercialization of advanced cellular therapies such as car-T, NK cell, TIL, MIL and other cellular immunotherapy products.


https://www.cognatebioservices.com/cognate-bioservices-secures-growth-capital-investment-from-ew-healthcare-to-continue-to-expand-commercial-manufacturing-capacity-and-services-for-the-cellular-therapies-industry/

Flipper,

Why not mention DC in the latest PR (in bold)? Hiding something or a hint?


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News